Skip to main content
Caplight Logo









Orphalan SA

Orphalan SA

Private
ParisHealthcare & Life Scienceshttps://www.orphalan.com/

Company Overview

Orphalan SA is a biotechnology company that develops and commercializes innovative therapies for patients with rare and debilitating diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

orphan drugsrare disease treatmentWilson's diseasecopper chelating agentspecialty pharmaceuticalsorphan drug developmentmetabolic disorderstrientinebiotechrare disease pharmaclinical registryorphan drug market

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orphalan SA Comparables

Compare Orphalan SA with similar companies based on industry and business-model similarity.

Orphalan SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Waymade PLC
85%
Recordati SpA
83%
Bausch Health Companies
80%

Orphalan SA Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Mai Mishir

Head of Global Regulatory Affairs, reporting to the CEO

Executive Team

Nabeel Zubair

Chief Technology Officer

Executive Team

Angelita Briffa

Chief Financial Officer

Executive Team

Orphalan SA Investors

Notable investors and investment history

Orphalan SA investors
InvestorRounds
Advent Life SciencesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 129% MoM, reaching 1.1K.

  • Jan 4, 2026

    Monthly visitors grew 99% MoM.

Orphalan SA Filings

Explore SEC and related filing metadata, where available.

Orphalan SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Orphalan SA's valuation, stock price, and market status.

Is Orphalan SA a public or private company?

Orphalan SA is a private company.

What is the current stock price of Orphalan SA?

Orphalan SA is a private company with no public stock price. Caplight tracks Orphalan SA's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Orphalan SA worth (valuation)?

Valuation information for Orphalan SA is not publicly available.

Can I buy Orphalan SA stock?

Orphalan SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Orphalan SA's last funding round?

Funding round information for Orphalan SA is not publicly available.

Who are the main investors in Orphalan SA?

Key investors in Orphalan SA include Advent Life Sciences.

Will Orphalan SA IPO soon?

No public IPO plans have been announced for Orphalan SA.

How can I track Orphalan SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orphalan SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range139
Year Founded2011
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?